CAS 60166-93-0
:Iopamidol
Descrição:
Iopamidol é um agente de contraste não iônico, solúvel em água, utilizado principalmente em imagem médica, particularmente em tomografias computadorizadas (TC) e angiografias. Pertence à classe de meios de contraste iodados, que aumentam a visibilidade das estruturas internas na imagem radiográfica. A fórmula química de Iopamidol indica que contém iodo, que é responsável por sua radiopacidade. Este composto é caracterizado por sua baixa osmolalidade, o que reduz o risco de reações adversas em comparação com agentes de contraste mais antigos. Iopamidol é tipicamente administrado por via intravenosa e é conhecido por seu perfil de toxicidade relativamente baixo, tornando-o adequado para uma ampla gama de pacientes, incluindo aqueles com função renal comprometida. Além disso, é estável em condições normais e possui um pH neutro, o que contribui para sua compatibilidade com tecidos biológicos. Assim como todos os agentes de contraste, o monitoramento de reações alérgicas e da função renal é essencial durante seu uso. No geral, Iopamidol é uma ferramenta vital na imagem diagnóstica moderna, facilitando o diagnóstico preciso e o planejamento do tratamento.
Fórmula:C17H22I3N3O8
InChI:InChI=1/C17H22I3N3O8/c1-6(28)15(29)23-14-12(19)9(16(30)21-7(2-24)3-25)11(18)10(13(14)20)17(31)22-8(4-26)5-27/h6-8,24-28H,2-5H2,1H3,(H,21,30)(H,22,31)(H,23,29)/t6-/m0/s1
Chave InChI:InChIKey=XQZXYNRDCRIARQ-LURJTMIESA-N
SMILES:C(NC(CO)CO)(=O)C1=C(I)C(C(NC(CO)CO)=O)=C(I)C(NC([C@H](C)O)=O)=C1I
Sinónimos:- (-)-(S)-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-(2-hydroxypropanoylamino)-2,4,6-triiodo-benzene-1,3-dicarboxamide
- 1,3-Benzenedicarboxamide, N,N′-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[(2-hydroxy-1-oxopropyl)amino]-2,4,6-triiodo-, (S)-
- 1,3-Benzenedicarboxamide, N,N′-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxy-1-oxopropyl]amino]-2,4,6-triiodo-
- 1,3-Benzenedicarboxamide, N<sup>1</sup>,N<sup>3</sup>-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxy-1-oxopropyl]amino]-2,4,6-triiodo-
- 1-N,3-N-Bis(1,3-dihydroxypropan-2-yl)-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodobenzene-1,3-dicarboxamide
- 1-N,3-N-bis(1,3-dihydroxypropan-2-yl)-5-[(2S)-2-hydroxypropanamido]-2,4,6-triiodobenzene-1,3-dicarboxamide
- B 15000
- Gastromiro
- Iopamidol
- Iopamidol 300
- Iopamiro
- Iopamiro 370
- Iopamiron
- Iopamiron 300
- Iopamiron 370
- Isovue
- Isovue 300
- Isovue 370
- Jopamiron 200
- N,N'-bis(1,3-dihydroxypropan-2-yl)-5-[(2-hydroxypropanoyl)amino]-2,4,6-triiodobenzene-1,3-dicarboxamide
- N,N'-bis(1,3-dihydroxypropan-2-yl)-5-{[(2S)-2-hydroxypropanoyl]amino}-2,4,6-triiodobenzene-1,3-dicarboxamide
- N-(1,3-Dihydroxypropan-2-yl)-3-{[(1,3-dihydroxypropan-2-yl)amino]methyl}-5-{[(2S)-2-hydroxypropanoyl]amino}-2,4,6-triiodobenzamide
- N-[2-hydroxy-1-(hydroxymethyl)ethyl]-3-[[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]methyl]-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodo-benzamide
- N<sup>1</sup>,N<sup>3</sup>-Bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxy-1-oxopropyl]amino]-2,4,6-triiodo-1,3-benzenedicarboxamide
- Niopam
- Niopam 300
- Oypalomin
- Oypalomin 150
- Solutrast
- Solutrast 370
- benzamide, N-[2-hydroxy-1-(hydroxymethyl)ethyl]-3-[[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]methyl]-5-[[(2S)-2-hydroxy-1-oxopropyl]amino]-2,4,6-triiodo-
- 1,3-Benzenedicarboxamide, N1,N3-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxy-1-oxopropyl]amino]-2,4,6-triiodo-
- N1,N3-Bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxy-1-oxopropyl]amino]-2,4,6-triiodo-1,3-benzenedicarboxamide
- 1,3-benzenedicarboxamide,n,n’-bis(2-hydroxy-1-(hydroxymethyl)ethyl)-5-((2-hydr
- jopamiron200
- l-(+)-n,n’-bis(2-hydroxy-1-hydroxymethylethyl)-2,4,6-triiodo-5-lactamideisop
- l-5alpha-idrossipropionilamino-2,4,6-triiodoisoftal-di(1,3-diidrossi-2-propi
- N,N'-BIS(1,3-DIHYDROXYPROPAN-2-YL)-5-(2-HYDROXYPROPANOYLAMINO)-2,4,6-TRIIODO-BENZENE-1,3-DICARBOXAMIDE
- l-5alpha-hydroxypropionylamino-2,4,6-triiodoisophthalicaciddi(1,3-dihydroxy
- N,N'-Bis(2-hydroxy-1-(hydroxymethyl)ethyl)-5-((2-hydroxy-1-oxopropyl)amino)-2,4,6-triiodo-1,3-Benzenedicarboxamide
- niopam300
- 6-triiodo-(s)-oxy-1-oxopropyl)amino)-
- hthalamide
- lamide)
- Ver mais sinónimos
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
14 produtos.
Iopamidol
CAS:Fórmula:C17H22I3N3O8Pureza:>95.0%(T)(HPLC)Cor e Forma:White to Almost white powder to crystalPeso molecular:777.09Iopamidol
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C17H22I3N3O8Cor e Forma:White Off-White PowderPeso molecular:776.85411Iopamidol
CAS:<p>Iopamidol (SQ-13396) is a benzenedicarboxamide compound. It has a role as a radioopaque medium, an environmental contaminant and a xenobiotic.</p>Fórmula:C17H22I3N3O8Pureza:99.39% - 99.8%Cor e Forma:White Crystalline Powder White Crystalline PowderPeso molecular:777.09Iopamidol
CAS:Fórmula:C17H22I3N3O8Pureza:≥ 97.0%Cor e Forma:White to almost white crystalline powderPeso molecular:777.09Iopamidol
CAS:<p>Applications Nonionic radiocontrast medium. Diagnostic aid (radiopaque medium).<br>References Drayer, B., et al.: Am. J. Neuroradiol., 3, 59 (1982), Molyneux, A.J., et al.: Br. J. Radiol., 55, 117 (1982), Sovak, M., et al.: Radiology, 142, 115 (1982), Felder, E., et al.: Anal. Profiles Drug Subs., 17, 115 (1988),<br></p>Fórmula:C17H22I3N3O8Cor e Forma:WhitePeso molecular:777.09Iopamidol
CAS:<p>Iopamidol is a radiocontrast agent that is used in diagnostic imaging to improve the visibility of blood vessels and other structures. Iopamidol is a salt of sodium and iopamidol, which consists of iodine, water, and two types of organic molecules. The organic molecules are either non-ionic surfactants or quaternary ammonium compounds. Iopamidol has been shown to have genotoxic activity in vitro. It also has potential for nephrotoxicity when given intravenously. This drug is excreted by the kidneys with a half-life of about 2 hours. Its pharmacokinetic properties can be modified by changes in body mass index and congestive heart failure.</p>Fórmula:C17H22I3N3O8Pureza:Min. 95%Peso molecular:777.09 g/mol














